+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 4
Age: 18Years +
All Genders
ID06637332

Comparison of Daptomycin and Vancomycin Injections for Treating MRSA Bloodstream Infection

Led by Todd C. Lee MD MPH FIDSA · Updated on 2026-09-09

300

Participants Needed

20

Research Sites

43 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating two commonly used treatments, daptomycin and vancomycin, for patients with methicillin-resistant Staphylococcus aureus MRSA bloodstream infections. This open-label randomized controlled trial is a sub-study of the larger Staphylococcus aureus Network Adaptive Platform SNAP trial and aims to compare these therapies to understand their outcomes in treating MRSA bacteremia. Participants receive either daptomycin by injection at a dose decided by their treating clinician but no less than 6 mg per kg of body weight, or vancomycin by injection with dosing tailored to achieve specific blood levels based on local standards. Both treatments are given through injections, and participants are randomly assigned to one of these two groups. During the study, participants are monitored for outcomes including the desirability of their overall health status 90 days after enrollment, clinical failure, serious adverse events, death from any cause, infectious complications, and specific side effects like muscle inflammation and eosinophilic pneumonia. These outcomes are assessed within 90 days post-enrollment, with safety monitoring extending up to 42 days for certain side effects. The study involves regular assessments to evaluate these measures and ensure participant safety throughout the trial period.

CONDITIONS

Brief Title

Daptomycin vs. Vancomycin for the Treatment of Methicillin Resistant S. Aureus Bacteremia

Research Team

L

Lina Petrella

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here